Business Description
MediPharm Labs Corp
NAICS : 325412
SIC : 3741
ISIN : CA58504D1006
Compare
Compare
Traded in other countries / regions
LABS.CanadaMEDIF.USAMLZ.Germany IPO Date
2019-02-19Description
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.02 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -2.75 | |||||
| Beneish M-Score | -3.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -29.5 | |||||
| 3-Year EBITDA Growth Rate | 57.8 | |||||
| 3-Year EPS without NRI Growth Rate | 54.1 | |||||
| 3-Year FCF Growth Rate | 52.5 | |||||
| 3-Year Book Growth Rate | -36 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.31 | |||||
| 9-Day RSI | 39.47 | |||||
| 14-Day RSI | 42.47 | |||||
| 6-1 Month Momentum % | -5.17 | |||||
| 12-1 Month Momentum % | 13.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.21 | |||||
| Quick Ratio | 2.36 | |||||
| Cash Ratio | 1.22 | |||||
| Days Inventory | 129.08 | |||||
| Days Sales Outstanding | 59.59 | |||||
| Days Payable | 37.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.2 | |||||
| Shareholder Yield % | -1.41 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.16 | |||||
| Operating Margin % | -29.29 | |||||
| Net Margin % | -30.1 | |||||
| FCF Margin % | -6.49 | |||||
| ROE % | -23.44 | |||||
| ROA % | -19.03 | |||||
| ROIC % | -27.93 | |||||
| ROC (Joel Greenblatt) % | -33.74 | |||||
| ROCE % | -22.65 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.61 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.59 | |||||
| EV-to-EBIT | -1.08 | |||||
| EV-to-EBITDA | -1.42 | |||||
| EV-to-Forward-EBITDA | -10.38 | |||||
| EV-to-Revenue | 0.31 | |||||
| EV-to-Forward-Revenue | 0.25 | |||||
| EV-to-FCF | -4.8 | |||||
| Price-to-Net-Current-Asset-Value | 0.88 | |||||
| Price-to-Net-Cash | 3.52 | |||||
| Earnings Yield (Greenblatt) % | -92.59 | |||||
| FCF Yield % | -10.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediPharm Labs Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 26.415 | ||
| EPS (TTM) (€) | -0.028 | ||
| Beta | 1.49 | ||
| Volatility % | 37.23 | ||
| 14-Day RSI | 42.47 | ||
| 14-Day ATR (€) | 0.002873 | ||
| 20-Day SMA (€) | 0.03961 | ||
| 12-1 Month Momentum % | 13.99 | ||
| 52-Week Range (€) | 0.0346 - 0.07 | ||
| Shares Outstanding (Mil) | 411.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediPharm Labs Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediPharm Labs Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
MediPharm Labs Corp Frequently Asked Questions
What is MediPharm Labs Corp(FRA:MLZ)'s stock price today?
The current price of FRA:MLZ is €0.04. The 52 week high of FRA:MLZ is €0.07 and 52 week low is €0.03.
When is next earnings date of MediPharm Labs Corp(FRA:MLZ)?
The next earnings date of MediPharm Labs Corp(FRA:MLZ) is .
Does MediPharm Labs Corp(FRA:MLZ) pay dividends? If so, how much?
MediPharm Labs Corp(FRA:MLZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers